MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1
The oncoprotein transcription factor MYC is a major driver of malignancy and a highly validated but challenging target for the development of anticancer therapies. Novel strategies to inhibit MYC may come from understanding the co-factors it uses to drive pro-tumorigenic gene expression programs, pr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications Ltd
2021-01-01
|
Colección: | eLife |
Materias: | |
Acceso en línea: | https://elifesciences.org/articles/60191 |